- Idexx Laboratories (NASDAQ:IDXX -0.9%) Q4 results: Revenues: $352M (-0.6%); COGS: $169.8M (+2.7%); R&D Expense: $24.9M (+10.7%); SG&A: $122.5M (+16.9%); Operating Income: $34.8M (-43.2%); Net Income: $26M (-40.0%); EPS: $0.54 (-34.1%).
- FY2014 results: Revenues: $1,485.8M (+7.9%); COGS: $669.7M (+7.9%); R&D Expense: $98.3M (+11.7%); SG&A: $457.6M (+14.0%); Operating Income: $260.3M (-2.4%); Net Income: $181.9M (-3.1%); EPS: $3.58 (+2.9%); Quick Assets: $322.5M (+15.5%); CF Ops: $235.8M (-4.1%).
-
2015 Guidance: Revenue: $1,640M - 1,660M from $1,690M - 1,710M; EPS: $4.33 - 4.43 from $4.38 - 4.48.